News
An unexpected logo change at China’s securities regulator is being teasingly celebrated by stock investors as heralding an ...
4d
MyChesCo on MSNArbutus Biopharma Reacquires China Rights to Imdusiran, Forms Scientific Advisory BoardWARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced it has reacquired full global rights to its lead RNAi ...
The Asia Society Policy Institute’s Center for China Analysis aims to become a leading global think tank committed to decoding China's complexities with an "inside-out" approach by offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results